So far, the major classes of metalbased anticancer drugs include platinumii. Update of the preclinical situation of anticancer platinum complexes. In this video we discuss the mechanism of action of the anticancer drug cisplatin, which is an example of a platinum containing compound with anticancer properties. Anticancer characteristics and ototoxicity of platinumii amine. Metalbased anticancer agents covers the interdisciplinary world of inorganic drug discovery and development by introducing the most prominent compound classes based on different transition metals, discussing emerging. The application of inorganic chemistry to medicine is a rapidly developing field, and novel therapeutic and diagnostic metal complexes are now having. Formation of carbonato and hydroxo complexes in the reaction of platinum anticancer drugs. The resultant complexes, containing one coordinated water ligand, then.
Monofunctional platinumii anticancer complexes based on. A computational approach to the effects of solvent on the structural, electronic, spectroscopic 195 pt nmr and ir, and thermochemical properties of a thirdgeneration anticancer drug. The aquatedactivated platinum complexes can react with nucleophilic centers on purine bases of dna, particularly the n7 positions of guanosine and adenosine residues. Platinum complexes which are most studied metal complexes due to their importance as adjuvant therapy of cancers aiming to induce tumorcelldeath. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development. Cisplatin and other bivalent platinum complexes are effective against a number of.
A multifunctional nanobody drug conjugate ndc was constructed in this work for the targeted delivery of a platinum prodrug and an mri contrast agent. Anticancer activity of palladiumbased complexes against. Pdf the application of inorganic chemistry to medicine is a rapidly developing field, and novel therapeutic and diagnostic metal complexes are now. Platinum complexes as anticancer agents bentham science.
However, the disadvantages of these drugs are very painful on patients, such as nephrotoxicity and ototoxicity. These include testicular cancer, ovarian cancer, cervical cancer, breast cancer, bladder cancer, head and neck cancer, esophageal cancer, lung cancer, mesothelioma, brain tumors and neuroblastoma. Thus, a platinum based complex was sought with a different structure. Platinum anticancer drugs since cisplatin, the first fda approved ptii anticancer drug, went on the market in 1978, platinum anticancer drugs have been a great success. Barnard johnson matthey technology centre it is now 20 years since the publication of the antitumour activity of platinum compounds by barnett rosenberg and his colleagues. Anticancer drugs, metal ion complex, transition metal compound. Understanding and improving platinum anticancer drugs ncbi. Platinum complexes with bioactive nitroxyl radicals. The first experiments showing that platinum complexes could have anticancer activity are rooted in the serendipitous observations made by rosenberg and coworkers when. Palladiumbased complexes are appealing alternative metalbased drugs because of significant similarities regarding structure and coordination chemistry with the platinum agents. This channel is dedicated to students of chemistry, medicine, pharmacy, biology, physics, agriculture and other branches studying chemistry. Interaction of antitumor platinum complexes with human liver.
Breast and ovarian cancers are among the 10 leading cancer types in females with mortalities of 15% and 6%, respectively. However, this has been challenged by contemporary evidence suggesting that many chemotherapeutics, including platinum based agents, stimulate the innate andor adaptive immune system and. Modular design of nanobodydrug conjugates for targeted. It is given by injection into a vein common side effects include bone marrow suppression, hearing problems, kidney problems. Their anticancer activities are also extended to hodgkins and nonhodgkins. Nanoformulation as a tool for improve the pharmacological. Platinum resistance in breast and ovarian cancer cell lines. The discovery and development of cisplatin journal of.
Oncological in vivo research of platinum complexes is supported by many in vitro experiments on oligoand polynucleotides, see e. Nanoformulation as a tool for improve the pharmacological profile of platinum and ruthenium anticancer drugs, descriptive inorganic chemistry researches of metal compounds, takashiro akitsu, intechopen, doi. Polynuclear polyamine complexes, in particular, have attracted special attention, since they were found to yield dna adducts not available to conventional drugs through longdistance intra and interstrand crosslinks and to. Oxaliplatin is the most recent platinum anticancer drug to have. The use of metalbased drugs presents the most important strategy in the development of new anticancer and antimicrobial agents. Gold coordination complexes as anticancer agents bentham. The effect of three novel complexes of ptii and three complexes of pdii with 2acetylpyridine thiosemicarbazone hactsc on sister chromatid exchange sce rates and human lymphocyte proliferation kinetics on a molar basis was studied. Oxaliplatin is the most recent platinum anticancer drug to have gained international approval for marketing. A major sideeffect of platinumbased anticancer drugs is damage to auditory hair. Multinuclear platinum complexes as anticancer drugs. As palladium is a congener of platinum, its character is similar to that of platinum. Scope of metal complexes in the treatment of cancer. Development and action of anticancer agents of the series metal ions in life sciences centers on biological, medicinal inorganic chemistry.
Several multinuclear platinum complexes have entered clinical trials in recent years, with varying results. Given that these complexes derive their activity from the novel adducts they form with dna, three important aspects of their binding are discussed. Owing to the similar mechanism of dna binding between cisplatin and the secondgeneration platinum metal complexes, cell lines resistant to cisplatin were also resistant to drugs such as carboplatin. The development of metal complexes with platinum central atoms such as cisplatin or carboplatin had an enormous impact on current cancer chemotherapy.
Full text metal complexes in cancer therapy an update from drug. Multinuclear platinum complexes as anticancer drugs multinuclear platinum complexes as anticancer drugs wheate, nial j collins, j. The widespread use of platinum agents in the treatment of cancer began with the discovery of the antineoplastic activity of cisplatin by barnett rosenberg in the 1960s 2. Metalbased anticancer drugs are among the most successful therapeutic agents, as evidenced by the frequent prescription of selected platinum and arsenic compounds to patients. Platinum resistance in breast and ovarian cancer cell. Anticancer characteristics and ototoxicity of platinumii. The drug, marketed as platinol with the generic name cisplatin, received fda approval in 1979 and is today one of the leading anticancer agents. Biological carriers conjugated to cisplatin analogs have improved specificity for tumor tissue. Platinum anticancer drugs which are in clinical use and undergoing clinical trials. Metal complexes in cancer therapy an update from drug design perspective umar ndagi, ndumiso mhlongo, mahmoud e soliman molecular modelling and drug design research group, school of health sciences, university of kwazulunatal, westville, durban, south africa abstract. These complexes show excellent solubility in water. The distinguishing feature of phenanthriplatin is the presence of a benzannulated nheterocyclic ligand, phenanthridine benzoc.
Metal complexes in cancer therapy an update from drug. Platinum based antineoplastic drugs informally called platins are chemotherapeutic agents used to treat cancer. The am mine groups of the polyamine linkers 25 27, or the central platinum centre in 24, provide groups capable of hydrogen bond formation with dna atoms such as the o6 of guanine or the o3 of thymine. Pdf platinum complexes as anticancer agents researchgate. Such nonclassical platinum complexes include ptiv prodrugs, complexes with trans stereochemistry, polyplatinum compounds, platinumtethered intercalators. Their clinical success is, however, limited much effort has been put into the development of new platinum anticancer complexes, but none of them has reached worldwide clinical application so far. Platinum has the ability, in certain chemical forms, to inhibit the division of living cells. Cisplatin cisdiaminedichloroplatinum ii is a platinumbased chemotherapy drug that has been fdaapproved for treatment of a variety of cancers including sarcomas, smallcell lung cancer, ovarian cancer, lymphomas, and germ cell tumors. Cisplatin is a chemotherapy medication used to treat a number of cancers.
The cellular target of the three fdaapproved platinum drugs, as well as many related compounds that have been investigated, is nuclear dna. Platinum anticancer agents twenty years of continuing development by c. Discovery of anticancer agents started after 1940s when nitrogen mustard was used most of the agents were discovered in 19501970. Multinuclear platinum complexes as anticancer drugs sciencedirect. Platinum complexes are cytotoxic agents yet the paradigm in cancer. Some tumors have a natural or acquired resistance to one class of drugs and, by applying several, it is hoped that an effective reduction in tumor mass can be. Pt chemotherapeutics make up roughly 50% of all chemotherapeutic drug regimens. Platinum and palladium polyamine complexes as anticancer. Ptiv, cis, trans, amine, diamine, coordination complexes, multinuclear complexes, dna, cytotoxic activity, tumor cell lines. Platinumbased drugs have become a mainstay of cancer therapy. Platinum complexes article about platinum complexes by. Platinum amine complexes and their anti cancer activities on free shipping on qualified orders.
Cisplatin ptnh 3 2 cl 2 is a platinum complex and a major anticancer drug, but it has a few problems such as nephrotoxicity and drug resistance. Two platinumii complexes with heterocyclic ligands, pyriplatin and. Anticancer drugs the anticancer drug either kill cancer cells or modify their growth. Understanding and improving platinum anticancer drugs.
Some of the platinum based antitumor drugs like cisplatin, carboplatin and oxaliplatin, have several disadvantages including side effects, cisplatinresistant tumors, limited solubility in aqueous media, and so on. Despite the pervasiveness of platinum drugs in cancer treatment regimens. Platinumbased anti cancer drugs are the backbone of chemotherapy, they play a crucial role in treating various malignant tumor. Cisplatin, the first platinum anticancer drug, began to be used in treatment in 1977. Platinum based drugs cisplatin, carboplatin and oxaliplatin are widely used in the therapy of human neoplasms. Targeted ptii agents, nanoparticle delivery, and ptiv prodrugs.
Metal complexes as drugs and chemotherapeutic agents n. Platinum drugs are used in both pt ii and ptiv oxidation states. The initial report of the therapeutic anticancer properties of a dinuclear platinum complex in 1988 started a new paradigm in platinum based chemotherapy. Chemistry and biochemistry of a leading anticancer drug. Trx effects on anticancer drug resistance are complex and depend strictly on the tissue type. Platinum complex drugs commonly used in chemotherapy as anticancer agents. Summary some platinum coordination complexes are active anticancer drugs in animals and man. Platinum drug distribution in cancer cells and tumors. Historically, the contribution of the immune system to chemotherapy outcomes has been neglected, as anticancer drugs were believed to be immunosuppressive. However, the spectrum of cancers that can be treated with platinum agents is narrow and treatment efficacy suffers. Thus, palladium complexes are expected to provide alternatives to cisplatin.
This drug and the resistance to cisplatin are described in chapter 15. Since the introduction of cisplatin to oncology in 1978, ptii and pdii compounds have been intensively studied with a view to develop the improved anticancer agents. Monofunctional platinum ii complexes have properties unlike those found in the bifunctional anticancer drug cisplatin and could be able to target cancer cells without producing the ototoxic sideeffects commonly associated with this chemotherapy compound. Platinumbased antineoplastic drugs informally called platins are chemotherapeutic agents used to treat cancer. The serendipitous discovery of the antitumor activity of cisdiamminodichloroplatinumii cisplatin by barnett rosenberg in the 1960s is a landmark in metallodrugbased chemotherapy. Goldi and goldiii complexes, the last isostructural and isoelectronic with platinum ii complexes, are potentially attractive as anticancer agents. This new class of chemotherapeutics was discovered during the course of. Phenanthriplatin, cisptnh 3 2 phenanthridineclno 3, is a leading preclinical anticancer pt complex with significantly greater efficacy and a distinct spectrum of activity compared to clinically approved drugs such as cisplatin cisdiamminedichloroplatinum. Metalbased anticancer agents current cancer research within the lippard lab is focused on understanding platinum anticancer drugs and developing nonclassical anticancer complexes, including monofunctional ptii, dual threat ptiv, and other third row transition metal complexes. Also, the effect of ptii and pdii complexes against leukemia p388 was investigated. A new era of metalbased drugs started in the 1960s, heralded by the discovery of potent platinumbased complexes, commencing with cisplatin h.
Farrell virginia commonwealth university, richmond, va, usa 9. Chemotherapy radiotherapy immunotherapy surgery 10. Platinum is usually given in combination with other drugs, commonly vinblastine and bleomycin for testicular cancer. These drugs are used to treat almost half of people receiving chemotherapy for cancer. The design of an effective anticancer agent is a complicated game that must encompass not only the drugs inherent inhibitory properties but also its delivery, dosage, and residence time in vivo. Cisplatin, as one of the leading metalbased drugs, is widely used in the treatment of cancer. The ndc can be specifically internalized into egfr positive cancer cells, resulting in higher therapeutic effect and lower sideeffects relative to cisplatin. Interaction of antitumor platinum complexes with human.
Over the past few decades, transition metal complexes have attracted considerable attention in medicinal inorganic chemistry, especially as synthetic metallonucleases and metalbased anticancer drugs that are able to bind to dna under physiological conditions. Significant side effects and drug resistance, however, have limited its clinical applications. In the past, metalbased compounds were widely used in the treatment of disease conditions, but the lack of clear. The discovery of this property in 1962 led to the development of platinum based drugs to treat a wide range of cancers. A platinumbased anticancer drug is any agent that contains one or more platinum. This combination chemotherapy, as it is known, has several objectives.
635 965 1429 1202 31 1288 11 1406 1016 467 309 822 700 1309 1483 722 529 1038 124 597 1109 155 863 546 430 978 1202 882 461 1180 328 512